Based on findings from cancer research, the role of the hypoxic tumor microenvironment in suppressing the type 1 interferon response and subsequent immune activation has steered autoimmunity research toward the immunomodulatory effects of hypoxia-induced activation of the hypoxia-inducible factor-1α (HIF-1α) pathway. This evidence concerns the gene HIF1A and cancer.